Literature DB >> 3472771

The c-erbB-2 gene encodes a receptor-like protein with tyrosine kinase activity.

K Toyoshima, K Semba, T Akiyama, S Ikawa, T Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3472771     DOI： 10.1101/sqb.1986.051.01.111

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  7 in total

1.  Evolution, expression, and chromosomal location of a novel receptor tyrosine kinase gene, eph.

Authors:  Y Maru; H Hirai; M C Yoshida; F Takaku
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

2.  Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer.

Authors:  Alicia F C Okines; David Cunningham
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

3.  A cell mutant that exhibits temperature-dependent sensitivity to transformation by various oncogenes.

Authors:  S Kizaka; A Hakura
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

4.  Markers of bile duct tumors.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Alessandra Rando; Mario Uccello; Francesco Basile; Antonio Biondi; Santo Carnazzo; Innocenza Alessandria; Clorinda Mazzarino
Journal:  World J Gastrointest Oncol       Date:  2011-04-15

5.  Arecoline induced disruption of expression and localization of the tight junctional protein ZO-1 is dependent on the HER 2 expression in human endometrial Ishikawa cells.

Authors:  Sarbani Giri; Kevin M Poindexter; Shyam N Sundar; Gary L Firestone
Journal:  BMC Cell Biol       Date:  2010-07-06       Impact factor: 4.241

6.  HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285.

Authors:  Shinji Takagi; Hiroshi Banno; Akira Hayashi; Toshiya Tamura; Tomoyasu Ishikawa; Yoshikazu Ohta
Journal:  Oncoscience       Date:  2014-03-24

7.  ERBB2 increases metastatic potentials specifically in androgen-insensitive prostate cancer cells.

Authors:  Jessica Tome-Garcia; Dan Li; Seda Ghazaryan; Limin Shu; Lizhao Wu
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.